Health
Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer treatment – News-Medical.Net
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkp…
Reviewed by Emily Henderson, B.Sc.Jul 9 2020
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Im…
Continue Reading
-
Noosa News21 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business20 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News21 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage
-
Business23 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy